1. |
Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: A population-based study. Lancet, 2006, 368(9540): 1005-1011.
|
2. |
潘文志, 金沁纯, 周达新. 房性功能性二尖瓣反流的定义及经导管缘对缘修复术对其治疗的可行性. 华西医学, 2021, 36(9): 1172-1176.
|
3. |
Condado JA, Acquatella H, Rodriguez L, et al. Percutaneous edge-to-edge mitral valve repair: 2-year follow-up in the first human case. Catheter Cardiovasc Interv, 2006, 67(2): 323-325.
|
4. |
Feldman T, Kar S, Elmariah S, et al. Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST Ⅱ. J Am Coll Cardiol, 2015, 66(25): 2844-2854.
|
5. |
Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med, 2018, 379(24): 2307-2318.
|
6. |
Mack MJ, Lindenfeld J, Abraham WT, et al. 3-year outcomes of transcatheter mitral valve repair in patients with heart failure. J Am Coll Cardiol, 2021, 77(8): 1029-1040.
|
7. |
Yeo KK, Yap J, Yamen E, et al. Percutaneous mitral valve repair with the MitraClip: Early results from the MitraClip Asia-Pacific Registry (MARS). EuroIntervention, 2014, 10(5): 620-625.
|
8. |
Tay E, Muda N, Yap J, et al. The MitraClip Asia-Pacific Registry: Differences in outcomes between functional and degenerative mitral regurgitation. Catheter Cardiovasc Interv, 2016, 87(7): E275-E281.
|
9. |
Bavry AA, Arnaoutakis GJ. Perspective to 2020 American College of Cardiology/American Heart Association (ACC/AHA) guideline for the management of patients with valvular heart disease. Circulation, 2021, 143(5): 407-409.
|
10. |
Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J, 2017, 38(36): 2739-2791.
|
11. |
Glower DD, Kar S, Trento A, et al. Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: Results of the EVEREST Ⅱ study. J Am Coll Cardiol, 2014, 64(2): 172-181.
|